Skip to content
ProJect Pharmaceutics
  • Home
  • About Us
  • Services
    • Drug Formulation Development
    • High Protein Concentration Formulations
    • Cytotoxic Drug Development
    • ADC Formulation Development
    • Virus Formulation Development
    • Liposomal Formulation Development
    • Lyophilization Process Development
    • Bulk Lyophilization Development
    • Aseptic Preclinical Batch Manufacturing
    • In-use Stability Studies
    • Technology Transfer to Fill&Finish
    • Analytical Services and Method Development
    • Downstream Process Development
    • Check your Lyo Cycle!
  • News
  • Media
  • Career
  • Contact
  • English

Month: June 2019

Join ProJect Pharmaceutics at Gene and Cell Therapy_Quality Developments to Commercialization Summit 2019

December 18, 2025June 1, 2019

ProJect Pharmaceutics is delighted to exhibit at the upcoming Gene and Cell Therapy_Quality Developments to Commercialization Summit, taking place in Berlin, Germany, June 5-6, 2019. We look forward to welcoming you at our booth.

Categories Conferences / Events

Archives

  • July 2026
  • June 2026
  • May 2026
  • April 2026
  • March 2026
  • February 2026
  • January 2026
  • December 2025
  • November 2025
  • October 2025
  • September 2025
  • February 2025
  • January 2025
  • December 2024
  • October 2024
  • July 2024
  • June 2024
  • May 2024
  • April 2024
  • March 2024
  • February 2024
  • January 2024
  • October 2023
  • June 2023
  • November 2022
  • May 2022
  • August 2021
  • July 2021
  • March 2020
  • October 2019
  • June 2019
  • September 2018
  • July 2018
  • June 2018
  • February 2018
  • September 2017
  • January 2017
  • October 2015
  • March 2015
  • January 2014
  • December 2013
  • July 2012
  • June 2012
  • May 2012
  • December 2011
  • September 2011
  • August 2011
  • May 2011

Get connected

See what we're up to by following along on social media.

Linkedin-in Xing Youtube Adc Envelope

About us

ProJect Pharmaceutics transforms proteins, peptides and ADCs/Cytotoxics into pioneering drugs.

ProJect Pharmaceutics was founded in 2010 and is managed by leading experts in protein formulation and pharmaceutical process development with many years of experience in bio-pharmaceutics.

PJP received CIR application approval for the years 2020-2025 for the benefit of our French customers.

Get in touch

ProJect Pharmaceutics GmbH
Fraunhoferstraße 22
D – 82152 Martinsried
Germany

E:

BiGEN acts as the Asian representative office of ProJect Pharmaceutics GmbH. For Asian customers, please click here

  • Home
  • Regulatory
  • Privacy Policy
  • Contact
© 2026 ProJect Pharmaceutics GmbH